Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xoma Royalty Corp (XOMA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xoma Royalty Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 791908.
Total stock buying since 2015: $32,925,040.
Total stock sales since 2015: $59,715,628.
Total stock option exercises since 2015: $1,530,582.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 40,924 | $1,024,946 | 1,079,559 | $28,543,206 | 71,132 | $0 |
| 2024 | 0 | $0 | 31,656 | $947,998 | 71,133 | $0 |
| 2023 | 39,849 | $739,662 | 0 | $0 | 0 | $0 |
| 2022 | 193,569 | $3,381,469 | 94,950 | $2,811,877 | 94,950 | $382,647 |
| 2021 | 0 | $0 | 9,027 | $309,319 | 5,699 | $66,763 |
| 2020 | 689,066 | $15,278,263 | 79,000 | $2,844,332 | 79,000 | $400,690 |
| 2019 | 401,108 | $8,618,515 | 28,130 | $601,217 | 28,000 | $142,239 |
| 2018 | 270,229 | $3,882,185 | 5,528 | $70,039 | 7,693 | $58,582 |
| 2017 | 0 | $0 | 116,081 | $2,258,932 | 68,518 | $276,125 |
| 2016 | 0 | $0 | 186,492 | $231,328 | 70,098 | $0 |
| 2015 | 0 | $0 | 13,392,330 | $21,097,380 | 480,384 | $203,536 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 2,000 | $50,780 | 0 | $0 | 0 | $0 |
| 2025-05 | 0 | $0 | 428,842 | $11,559,493 | 71,132 | $0 |
| 2025-04 | 33,000 | $836,685 | 0 | $0 | 0 | $0 |
| 2025-03 | 5,379 | $123,489 | 0 | $0 | 0 | $0 |
| 2025-01 | 545 | $13,992 | 650,717 | $16,983,713 | 0 | $0 |
| 2024-11 | 0 | $0 | 31,656 | $947,998 | 71,133 | $0 |
| 2023-10 | 2,750 | $38,677 | 0 | $0 | 0 | $0 |
| 2023-09 | 2,500 | $36,074 | 0 | $0 | 0 | $0 |
| 2023-05 | 12,350 | $244,177 | 0 | $0 | 0 | $0 |
| 2023-01 | 22,249 | $420,734 | 0 | $0 | 0 | $0 |
| 2022-09 | 193,569 | $3,381,469 | 0 | $0 | 0 | $0 |
| 2022-07 | 0 | $0 | 27,000 | $834,972 | 27,000 | $108,810 |
| 2022-03 | 0 | $0 | 67,950 | $1,976,905 | 67,950 | $273,837 |
| 2021-06 | 0 | $0 | 9,027 | $309,319 | 0 | $0 |
| 2021-03 | 0 | $0 | 0 | $0 | 5,699 | $66,763 |
| 2020-12 | 400,000 | $10,000,000 | 41,000 | $1,704,547 | 41,000 | $203,450 |
| 2020-11 | 0 | $0 | 38,000 | $1,139,785 | 38,000 | $197,240 |
| 2020-09 | 76,677 | $1,418,711 | 0 | $0 | 0 | $0 |
| 2020-08 | 79,409 | $1,500,365 | 0 | $0 | 0 | $0 |
| 2020-03 | 132,980 | $2,359,187 | 0 | $0 | 0 | $0 |
| 2019-12 | 373,195 | $8,210,290 | 0 | $0 | 0 | $0 |
| 2019-11 | 0 | $0 | 4,348 | $95,656 | 4,348 | $23,914 |
| 2019-09 | 0 | $0 | 23,652 | $503,649 | 23,652 | $118,325 |
| 2019-05 | 27,913 | $408,225 | 130 | $1,912 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-30 | Sitko Bradley (Chief Investment Officer) | Buy | 2,000 | 25.39 | 50,780 |
| 2025-05-20 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 10,482 | 25.38 | 266,033 |
| 2025-05-20 | Hughes Owen (Chief Executive Officer) | Sale | 25,637 | 25.38 | 650,667 |
| 2025-05-19 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 17,773 | .00 | 0 |
| 2025-05-19 | Hughes Owen (Chief Executive Officer) | Option Ex | 53,359 | .00 | 0 |
| 2025-05-16 | Lampert Mark N | Sale | 392,723 | 27.10 | 10,642,793 |
| 2025-04-07 | Sitko Bradley (Chief Investment Officer) | Buy | 2,000 | 24.70 | 49,400 |
| 2025-04-07 | Limber Joseph M | Buy | 5,243 | 25.60 | 134,220 |
| 2025-04-04 | Limber Joseph M | Buy | 6,822 | 25.41 | 173,312 |
| 2025-04-03 | Limber Joseph M | Buy | 17,935 | 25.33 | 454,293 |
| 2025-04-01 | Burns Thomas M. (SVP, Finance & CFO) | Buy | 1,000 | 25.46 | 25,460 |
| 2025-03-31 | Sitko Bradley (Chief Investment Officer) | Buy | 1,245 | 22.68 | 28,242 |
| 2025-03-21 | Sitko Bradley (Chief Investment Officer) | Buy | 4,134 | 23.04 | 95,247 |
| 2025-01-24 | Lampert Mark N | Sale | 650,717 | 26.10 | 16,983,713 |
| 2025-01-08 | Sitko Bradley (Chief Investment Officer) | Buy | 545 | 25.68 | 13,992 |
| 2024-11-13 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 9,775 | 29.94 | 292,663 |
| 2024-11-13 | Hughes Owen (Chief Executive Officer) | Sale | 21,881 | 29.95 | 655,335 |
| 2024-11-11 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 17,773 | .00 | 0 |
| 2024-11-11 | Hughes Owen (Chief Executive Officer) | Option Ex | 53,360 | .00 | 0 |
| 2023-10-03 | Sitko Bradley (Chief Investment Officer) | Buy | 250 | 13.89 | 3,472 |
| 2023-10-02 | Sitko Bradley (Chief Investment Officer) | Buy | 1,500 | 14.25 | 21,375 |
| 2023-10-02 | Hughes Owen (Exec Chairman and Interim CEO) | Buy | 1,000 | 13.83 | 13,830 |
| 2023-09-26 | Hughes Owen (Exec Chairman and Interim CEO) | Buy | 2,499 | 14.43 | 36,060 |
| 2023-09-25 | Hughes Owen (Exec Chairman and Interim CEO) | Buy | 1 | 14.65 | 14 |
| 2023-05-31 | Sitko Bradley (Chief Investment Officer) | Buy | 3,000 | 17.10 | 51,300 |
| 2023-05-24 | Hughes Owen (Interim CEO) | Buy | 1,032 | 23.79 | 24,551 |
| 2023-05-23 | Sitko Bradley (Chief Investment Officer) | Buy | 850 | 19.00 | 16,150 |
| 2023-05-23 | Hughes Owen (Interim CEO) | Buy | 968 | 23.41 | 22,660 |
| 2023-05-19 | Sitko Bradley (Chief Investment Officer) | Buy | 1,000 | 19.50 | 19,500 |
| 2023-05-16 | Sitko Bradley (Chief Investment Officer) | Buy | 500 | 23.21 | 11,606 |
| 2023-05-15 | Sitko Bradley (Chief Investment Officer) | Buy | 1,500 | 23.40 | 35,100 |
| 2023-05-12 | Sitko Bradley (Chief Investment Officer) | Buy | 2,000 | 18.83 | 37,660 |
| 2023-01-06 | Lampert Mark N | Buy | 3,249 | 21.98 | 71,419 |
| 2023-01-05 | Lampert Mark N | Buy | 19,000 | 18.39 | 349,315 |
| 2022-09-27 | Lampert Mark N | Buy | 1,682 | 16.89 | 28,408 |
| 2022-09-26 | Lampert Mark N | Buy | 6,360 | 16.83 | 107,051 |
| 2022-09-23 | Lampert Mark N | Buy | 16,600 | 16.50 | 273,850 |
| 2022-09-16 | Lampert Mark N | Buy | 48,586 | 17.89 | 869,056 |
| 2022-09-15 | Lampert Mark N | Buy | 11,150 | 17.96 | 200,276 |
| 2022-09-14 | Lampert Mark N | Buy | 52,882 | 17.25 | 912,108 |
| 2022-07-15 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 2,000 | 31.66 | 63,322 |
| 2022-07-15 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 2,000 | 4.03 | 8,060 |
| 2022-07-15 | Neal James R (CEO) | Sale | 25,000 | 30.87 | 771,650 |
| 2022-07-15 | Neal James R (CEO) | Option Ex | 25,000 | 4.03 | 100,750 |
| 2022-03-23 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 161 | 30.00 | 4,830 |
| 2022-03-23 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 161 | 4.03 | 648 |
| 2022-03-23 | Neal James R (CEO) | Sale | 1,111 | 30.02 | 33,347 |
| 2022-03-23 | Neal James R (CEO) | Option Ex | 1,111 | 4.03 | 4,477 |
| 2022-03-22 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 2,339 | 30.02 | 70,209 |
| 2022-03-22 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 2,339 | 4.03 | 9,426 |
| 2022-03-22 | Neal James R (CEO) | Sale | 2,339 | 30.02 | 70,209 |
| 2022-03-22 | Neal James R (CEO) | Option Ex | 2,339 | 4.03 | 9,426 |
| 2022-03-21 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 12,000 | 29.00 | 348,060 |
| 2022-03-21 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 12,000 | 4.03 | 48,360 |
| 2022-03-21 | Neal James R (CEO) | Sale | 50,000 | 29.00 | 1,450,250 |
| 2022-03-21 | Neal James R (CEO) | Option Ex | 50,000 | 4.03 | 201,500 |
| 2021-06-25 | Neal James R (CEO) | Sale | 9,027 | 34.27 | 309,319 |
| 2021-03-15 | Van Ness W Denman | Option Ex | 5,699 | 11.71 | 66,763 |
| 2020-12-15 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 15,000 | 41.53 | 623,025 |
| 2020-12-15 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 15,000 | 4.03 | 60,450 |
| 2020-12-15 | Neal James R (CEO) | Sale | 26,000 | 41.60 | 1,081,522 |
| 2020-12-15 | Neal James R (CEO) | Option Ex | 26,000 | 5.50 | 143,000 |
| 2020-12-11 | Perry Matthew D | Buy | 200,000 | 25.00 | 5,000,000 |
| 2020-12-11 | Lampert Mark N | Buy | 200,000 | 25.00 | 5,000,000 |
| 2020-11-23 | Neal James R (CEO) | Sale | 13,126 | 32.96 | 432,659 |
| 2020-11-23 | Neal James R (CEO) | Option Ex | 13,126 | 5.50 | 72,193 |
| 2020-11-20 | Neal James R (CEO) | Sale | 6,874 | 32.91 | 226,202 |
| 2020-11-20 | Neal James R (CEO) | Option Ex | 6,874 | 5.50 | 37,807 |
| 2020-11-05 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 8,000 | 26.74 | 213,904 |
| 2020-11-05 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 8,000 | 4.03 | 32,240 |
| 2020-11-05 | Neal James R (CEO) | Sale | 10,000 | 26.70 | 267,020 |
| 2020-11-05 | Neal James R (CEO) | Option Ex | 10,000 | 5.50 | 55,000 |
| 2020-09-23 | Lampert Mark N | Buy | 17,089 | 18.20 | 311,019 |
| 2020-09-22 | Lampert Mark N | Buy | 11,951 | 18.45 | 220,448 |
| 2020-09-21 | Lampert Mark N | Buy | 22,328 | 18.39 | 410,500 |
| 2020-09-04 | Lampert Mark N | Buy | 7,737 | 18.77 | 145,231 |
| 2020-09-01 | Lampert Mark N | Buy | 17,572 | 18.87 | 331,513 |
| 2020-08-31 | Lampert Mark N | Buy | 16,005 | 18.48 | 295,788 |
| 2020-08-28 | Lampert Mark N | Buy | 2,044 | 19.17 | 39,187 |
| 2020-08-25 | Lampert Mark N | Buy | 5,687 | 19.75 | 112,289 |
| 2020-08-24 | Lampert Mark N | Buy | 11,683 | 19.31 | 225,587 |
| 2020-08-21 | Lampert Mark N | Buy | 10,805 | 19.32 | 208,774 |
| 2020-08-20 | Lampert Mark N | Buy | 1,772 | 19.12 | 33,880 |
| 2020-08-19 | Lampert Mark N | Buy | 3,496 | 19.70 | 68,878 |
| 2020-08-18 | Lampert Mark N | Buy | 895 | 19.27 | 17,245 |
| 2020-08-14 | Lampert Mark N | Buy | 21,922 | 18.69 | 409,809 |
| 2020-08-13 | Lampert Mark N | Buy | 1,050 | 17.80 | 18,693 |
| 2020-08-12 | Lampert Mark N | Buy | 4,050 | 17.34 | 70,235 |
| 2020-03-25 | Lampert Mark N | Buy | 8,264 | 17.20 | 142,132 |
| 2020-03-23 | Neal James R (CEO) | Buy | 1,000 | 14.50 | 14,500 |
| 2020-03-20 | Neal James R (CEO) | Buy | 1,000 | 16.41 | 16,410 |
| 2020-03-18 | Lampert Mark N | Buy | 4,439 | 14.53 | 64,476 |
| 2020-03-17 | Lampert Mark N | Buy | 8,113 | 15.73 | 127,649 |
| 2020-03-16 | Lampert Mark N | Buy | 10,164 | 15.73 | 159,920 |
| 2020-03-13 | Lampert Mark N | Buy | 100,000 | 18.34 | 1,834,100 |
| 2019-12-19 | Lampert Mark N | Buy | 373,195 | 22.00 | 8,210,290 |
| 2019-11-06 | Neal James R (CEO) | Sale | 4,348 | 22.00 | 95,656 |
| 2019-11-06 | Neal James R (CEO) | Option Ex | 4,348 | 5.50 | 23,914 |
| 2019-09-20 | Neal James R (Chief Executive Officer) | Sale | 5,452 | 20.23 | 110,272 |
| 2019-09-20 | Neal James R (Chief Executive Officer) | Option Ex | 5,452 | 5.50 | 29,986 |
| 2019-09-19 | Burns Thomas M. (Sr. VP, Finance and CFO) | Sale | 4,171 | 21.59 | 90,064 |
| 2019-09-19 | Burns Thomas M. (Sr. VP, Finance and CFO) | Option Ex | 4,171 | 4.03 | 16,809 |
| 2019-09-19 | Neal James R (Chief Executive Officer) | Sale | 6,370 | 21.21 | 135,107 |
| 2019-09-19 | Neal James R (Chief Executive Officer) | Option Ex | 6,370 | 5.50 | 35,035 |
| 2019-09-18 | Burns Thomas M. (Sr. VP, Finance and CFO) | Sale | 3,829 | 21.96 | 84,092 |
| 2019-09-18 | Burns Thomas M. (Sr. VP, Finance and CFO) | Option Ex | 3,829 | 4.03 | 15,430 |
| 2019-09-18 | Neal James R (Chief Executive Officer) | Sale | 3,830 | 21.96 | 84,114 |
| 2019-09-18 | Neal James R (Chief Executive Officer) | Option Ex | 3,830 | 5.50 | 21,065 |
| 2019-05-14 | Lampert Mark N | Buy | 13,816 | 14.74 | 203,661 |
| 2019-05-13 | Lampert Mark N | Buy | 3,797 | 14.36 | 54,524 |
| 2019-05-10 | Lampert Mark N | Buy | 10,300 | 14.57 | 150,040 |
| 2019-05-10 | Van Ness W Denman (Director) | Sale | 130 | 14.71 | 1,912 |
| 2018-12-17 | Lampert Mark N | Buy | 25,000 | 14.19 | 354,800 |
| 2018-12-13 | Lampert Mark N | Buy | 24,253 | 14.41 | 349,534 |
| 2018-12-12 | Lampert Mark N | Buy | 2,810 | 14.75 | 41,447 |
| 2018-12-11 | Lampert Mark N | Buy | 9,400 | 14.50 | 136,271 |
| 2018-12-10 | Lampert Mark N | Buy | 18,081 | 14.54 | 262,970 |
| 2018-12-07 | Lampert Mark N | Buy | 32,015 | 14.77 | 472,765 |
| 2018-12-06 | Lampert Mark N | Buy | 10,927 | 14.80 | 161,697 |
| 2018-12-04 | Lampert Mark N | Buy | 4,171 | 14.99 | 62,514 |
| 2018-12-03 | Lampert Mark N | Buy | 806 | 14.90 | 12,009 |
| 2018-11-30 | Lampert Mark N | Buy | 4,823 | 14.85 | 71,616 |
| 2018-11-29 | Lampert Mark N | Buy | 10,016 | 14.93 | 149,538 |
| 2018-11-28 | Lampert Mark N | Buy | 8,288 | 15.11 | 125,264 |
| 2018-11-27 | Lampert Mark N | Buy | 11,396 | 15.24 | 173,675 |
| 2018-11-21 | Lampert Mark N | Buy | 25,000 | 15.00 | 374,900 |
| 2018-11-20 | Lampert Mark N | Buy | 37,482 | 13.68 | 512,716 |
| 2018-11-19 | Lampert Mark N | Buy | 9,771 | 13.93 | 136,061 |
| 2018-11-16 | Lampert Mark N | Buy | 10,849 | 13.82 | 149,987 |
| 2018-11-15 | Lampert Mark N | Buy | 21,141 | 13.31 | 281,365 |
| 2018-11-15 | Van Ness W Denman (Director) | Sale | 5,528 | 12.67 | 70,039 |
| 2018-11-15 | Van Ness W Denman (Director) | Option Ex | 7,693 | 7.62 | 58,582 |
| 2018-11-13 | Neal James R (CEO) | Buy | 4,000 | 13.26 | 53,056 |
| 2017-11-15 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 8,392 | 27.24 | 228,564 |
| 2017-11-15 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 8,392 | 4.03 | 33,819 |
| 2017-11-15 | Neal James R (CEO) | Sale | 26,145 | 27.22 | 711,588 |
| 2017-11-15 | Neal James R (CEO) | Option Ex | 26,145 | 4.03 | 105,364 |
| 2017-11-14 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 6,847 | 29.06 | 198,973 |
| 2017-11-14 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 6,847 | 4.03 | 27,593 |
| 2017-11-14 | Neal James R (CEO) | Sale | 8,583 | 29.01 | 249,009 |
| 2017-11-14 | Neal James R (CEO) | Option Ex | 8,583 | 4.03 | 34,589 |
| 2017-11-13 | Burns Thomas M. (SVP, Finance & CFO) | Sale | 6,983 | 31.35 | 218,917 |
| 2017-11-13 | Burns Thomas M. (SVP, Finance & CFO) | Option Ex | 6,983 | 4.03 | 28,141 |
| 2017-11-13 | Neal James R (CEO) | Sale | 11,568 | 31.28 | 361,835 |
| 2017-11-13 | Neal James R (CEO) | Option Ex | 11,568 | 4.03 | 46,619 |
| 2017-05-16 | Varian John (Director) | Sale | 39,540 | 6.25 | 246,927 |
| 2017-03-21 | Burns Thomas M. (VP, Finance & Chief Financial) | Sale | 2,598 | 5.40 | 14,029 |
| 2017-03-21 | Neal James R (VP Business Development) | Sale | 5,105 | 5.40 | 27,567 |
| 2017-02-01 | Neal James R (VP Business Development) | Sale | 195 | 4.51 | 880 |
| 2017-01-09 | Neal James R (VP Business Development) | Sale | 125 | 5.15 | 643 |
| 2016-12-21 | Varian John (Director) | Sale | 13,549 | 5.75 | 77,906 |
| 2016-12-21 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Sale | 3,230 | 5.75 | 18,572 |
| 2016-11-01 | Neal James R (VP Business Development) | Sale | 150 | 5.25 | 787 |
| 2016-10-07 | Neal James R (VP Business Development) | Sale | 2,500 | .45 | 1,120 |
| 2016-05-28 | Walbert Timothy P (Director) | Option Ex | 2,800 | .00 | 0 |
| 2016-05-28 | Van Ness W Denman (Director) | Option Ex | 3,150 | .00 | 0 |
| 2016-05-28 | Limber Joseph M (Director) | Option Ex | 2,800 | .00 | 0 |
| 2016-05-28 | Wyszomierski Jack L (Director) | Option Ex | 2,800 | .00 | 0 |
| 2016-03-22 | Burns Thomas M. (VP, Finance & Chief Financial) | Sale | 19,249 | .79 | 15,110 |
| 2016-03-22 | Neal James R (VP Business Development) | Sale | 19,813 | .79 | 15,553 |
| 2016-03-22 | Varian John (CEO) | Sale | 81,022 | .79 | 63,602 |
| 2016-03-22 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Sale | 14,785 | .79 | 11,606 |
| 2016-03-22 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Sale | 24,194 | .79 | 18,992 |
| 2016-03-18 | Varian John (CEO) | Option Ex | 36,907 | .00 | 0 |
| 2016-03-18 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Option Ex | 9,500 | .00 | 0 |
| 2016-03-18 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Option Ex | 12,141 | .00 | 0 |
| 2016-02-01 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Sale | 8,000 | 1.01 | 8,080 |
| 2015-12-28 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Sale | 8,000 | 1.37 | 10,936 |
| 2015-12-12 | Limber Joseph M (Director) | Option Ex | 5,600 | .00 | 0 |
| 2015-11-23 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Sale | 8,000 | 1.35 | 10,800 |
| 2015-10-26 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Sale | 8,000 | 1.04 | 8,360 |
| 2015-08-14 | Varian John (CEO) | Option Ex | 94,573 | .00 | 0 |
| 2015-08-14 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Option Ex | 16,264 | .00 | 0 |
| 2015-08-14 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Option Ex | 26,748 | .00 | 0 |
| 2015-07-22 | Baker Julian (Other) | Sale | 11,000,000 | 1.09 | 12,023,000 |
| 2015-07-15 | Varian John (CEO) | Sale | 10,000 | 4.49 | 44,870 |
| 2015-07-15 | Varian John (CEO) | Option Ex | 10,000 | 1.24 | 12,400 |
| 2015-07-15 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Sale | 5,000 | 4.60 | 22,990 |
| 2015-07-15 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Option Ex | 5,000 | 3.04 | 15,200 |
| 2015-07-10 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Sale | 29,000 | 4.55 | 131,979 |
| 2015-07-10 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Option Ex | 29,000 | 3.04 | 88,160 |
| 2015-07-09 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Sale | 4,400 | 4.55 | 20,020 |
| 2015-07-09 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Option Ex | 4,400 | 3.04 | 13,376 |
| 2015-06-15 | Varian John (CEO) | Sale | 10,000 | 3.64 | 36,360 |
| 2015-06-15 | Varian John (CEO) | Option Ex | 10,000 | 1.24 | 12,400 |
| 2015-05-28 | Walbert Timothy P (Director) | Option Ex | 5,600 | .00 | 0 |
| 2015-05-28 | Bowes William K Jr (Director) | Option Ex | 5,600 | .00 | 0 |
| 2015-05-28 | Van Ness W Denman (Director) | Option Ex | 6,300 | .00 | 0 |
| 2015-05-28 | Limber Joseph M (Director) | Option Ex | 2,800 | .00 | 0 |
| 2015-05-28 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Sale | 1,788 | 3.60 | 6,436 |
| 2015-05-28 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Option Ex | 4,666 | .00 | 0 |
| 2015-05-28 | Wyszomierski Jack L (Director) | Option Ex | 5,600 | .00 | 0 |
| 2015-05-15 | Varian John (CEO) | Sale | 10,000 | 3.34 | 33,400 |
| 2015-05-15 | Varian John (CEO) | Option Ex | 10,000 | 1.24 | 12,400 |
| 2015-04-15 | Varian John (CEO) | Sale | 10,000 | 3.86 | 38,610 |
| 2015-04-15 | Varian John (CEO) | Option Ex | 10,000 | 1.24 | 12,400 |
| 2015-04-06 | Kurland Fred (CFO & VP Finance) | Option Ex | 29,938 | .00 | 0 |
| 2015-03-23 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Sale | 32,742 | 3.94 | 128,872 |
| 2015-03-18 | Klein Thomas (Chief Commercial Officer) | Option Ex | 80,667 | .00 | 0 |
| 2015-03-18 | Varian John (CEO) | Option Ex | 36,907 | .00 | 0 |
| 2015-03-18 | Kurland Fred (CFO & VP Finance) | Option Ex | 10,875 | .00 | 0 |
| 2015-03-18 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Option Ex | 9,500 | .00 | 0 |
| 2015-03-18 | Rubin Paul D (Sr. VP Clinical Dev. & CMO) | Option Ex | 30,346 | .00 | 0 |
| 2015-03-16 | Varian John (CEO) | Sale | 10,000 | 3.72 | 37,220 |
| 2015-03-16 | Varian John (CEO) | Option Ex | 10,000 | 1.24 | 12,400 |
| 2015-02-17 | Varian John (CEO) | Sale | 10,000 | 3.52 | 35,190 |
| 2015-02-17 | Varian John (CEO) | Option Ex | 10,000 | 1.24 | 12,400 |
| 2015-02-02 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Sale | 5,000 | 3.52 | 17,620 |
| 2015-01-15 | Varian John (CEO) | Sale | 10,000 | 3.46 | 34,580 |
| 2015-01-15 | Varian John (CEO) | Option Ex | 10,000 | 1.24 | 12,400 |
| 2015-01-06 | Baker Julian (Director) | Sale | 1,000,000 | 3.86 | 3,860,000 |
| 2015-01-05 | Baker Julian (Director) | Sale | 1,003,300 | 3.81 | 3,824,579 |
| 2015-01-02 | Scannon Patrick J Md Phd (Exec. VP & CSO) | Sale | 5,000 | 3.55 | 17,755 |
| 2015-01-02 | Baker Julian (Director) | Sale | 212,100 | 3.55 | 753,803 |
Insider trading activities including stock purchases, stock sales, and option exercises of XOMA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xoma Royalty Corp (symbol XOMA, CIK number 791908) see the Securities and Exchange Commission (SEC) website.